Adverse reactions observed in at least 20 of patients treated with AMONDYS 45 and at least 5 more frequently than in the placebo group were AMONDYS 45 placebo upper respiratory tract infections 65 55 cough 33 26 pyrexia 33 23 headache 32 19 arthralgia 21 10 and oropharyngeal pain 21 7